These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 22137570
21. The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients. Erdogan M, Karadeniz M, Berdeli A, Tamsel S, Yilmaz C. Int J Immunogenet; 2009 Oct; 36(5):283-8. PubMed ID: 19744034 [Abstract] [Full Text] [Related]
23. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Diamanti-Kandarakis E, Paterakis T, Alexandraki K, Piperi C, Aessopos A, Katsikis I, Katsilambros N, Kreatsas G, Panidis D. Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699 [Abstract] [Full Text] [Related]
24. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses. Nagy B, Savli H, Molvarec A, Várkonyi T, Rigó B, Hupuczi P, Rigó J. Clin Chim Acta; 2008 Mar; 389(1-2):126-31. PubMed ID: 18167313 [Abstract] [Full Text] [Related]
25. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome. Hahn S, Fingerhut A, Khomtsiv U, Khomtsiv L, Tan S, Quadbeck B, Herrmann BL, Knebel B, Müller-Wieland D, Mann K, Janssen OE. Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827 [Abstract] [Full Text] [Related]
28. Evaluation of association between the CYP11alpha promoter pentannucleotide (TTTTA)n polymorphism and polycystic ovarian syndrome among Han Chinese women. Hao CF, Bao HC, Zhang N, Gu HF, Chen ZJ. Neuro Endocrinol Lett; 2009 Mar; 30(1):56-60. PubMed ID: 19300392 [Abstract] [Full Text] [Related]
31. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Skov V, Glintborg D, Knudsen S, Jensen T, Kruse TA, Tan Q, Brusgaard K, Beck-Nielsen H, Højlund K. Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058 [Abstract] [Full Text] [Related]
32. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome. Hu W, Qiao J, Yang Y, Wang L, Li R. Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057 [Abstract] [Full Text] [Related]
33. Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS. Celik O, Yesilada E, Hascalik S, Celik N, Sahin I, Keskin L, Ozerol E. Reprod Biomed Online; 2010 Apr; 20(4):492-8. PubMed ID: 20138007 [Abstract] [Full Text] [Related]
37. No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia. Marioli DJ, Koika V, Adonakis GL, Saltamavros AD, Karela A, Armeni AK, Tsapanos VS, Decavalas GO, Georgopoulos NA. Arch Gynecol Obstet; 2010 Jun; 281(6):1045-9. PubMed ID: 20012307 [Abstract] [Full Text] [Related]